When it comes to regulatory requirements facing the pharmaceutical industry, one thing is certain: change. This year was filled with newly enacted and proposed legislation and ongoing uncertainty. What does all this mean for your compliance program in 2024 – and what do you need to do to prepare?

Watch the webinar to learn more about:

• The future of the 340B program and its scope
• New state price transparency laws and the introduction of prescription drug affordability boards
• Impacts of the Inflation Reduction Act (IRA) on Medicare and pharmaceutical revenue
• The Final Rule / CMS

Featured Speakers

Kunal Akwalia

Senior Principal, Global Pricing and Contracting

IQVIA

Jesse Mendelsohn

Senior Vice President

Model N